Neuroprotective and disease-modifying effects of the ketogenic diet

Neuroprotective and disease-modifying effects of the ketogenic diet

Behav Pharmacol. Author manuscript; available in PMC 2008 May 5.
 
Published in final edited form as:

 

Reading it again.. Well worth it.

Abstract

The ketogenic diet has been in clinical use for over 80 years, primarily for the symptomatic treatment of epilepsy. A recent clinical study has raised the possibility that exposure to the ketogenic diet may confer long-lasting therapeutic benefits for patients with epilepsy. Moreover, there is evidence from uncontrolled clinical trials and studies in animal models that the ketogenic diet can provide symptomatic and disease-modifying activity in a broad range of neurodegenerative disorders including Alzheimer’s disease and Parkinson’s disease, and may also be protective in traumatic brain injury and stroke. These observations are supported by studies in animal models and isolated cells that show that ketone bodies, especially β-hydroxybutyrate, confer neuroprotection against diverse types of cellular injury. This review summarizes the experimental, epidemiological and clinical evidence indicating that the ketogenic diet could have beneficial effects in a broad range of brain disorders characterized by the death of neurons. Although the mechanisms are not yet well defined, it is plausible that neuroprotection results from enhanced neuronal energy reserves, which improve the ability of neurons to resist metabolic challenges, and possibly through other actions including antioxidant and anti-inflammatory effects. As the underlying mechanisms become better understood, it will be possible to develop alternative strategies that produce similar or even improved therapeutic effects without the need for exposure to an unpalatable and unhealthy, high-fat diet.

Keywords: Alzheimer’s disease, cellular energetics, epilepsy, ketone bodies, ketogenic diet, mitochondria, neuroprotection, Parkinson’s disease, stroke, traumatic brain injury
 
 
 
Posted in Aging, dietary, epigenetics, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged , , , , |

Crowdsourcing Diagnosis for Patients With Undiagnosed Illnesses: An Evaluation of CrowdMed

Crowdsourcing Diagnosis for Patients With Undiagnosed Illnesses: An Evaluation of CrowdMed

http://www.jmir.org/2016/1/e12/

 

1Houston Veterans Affairs Center for Innovations in Quality, Effectiveness and Safety, Health Services Research and Development, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States

2Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, TX, United States

3Department of Biomedical Informatics, University of California San Diego, La Jolla, CA, United States

Corresponding Author:

Hardeep Singh, MD, MPH

 

Houston Veterans Affairs Center for Innovations in Quality, Effectiveness and Safety

Michael E. DeBakey Veterans Affairs Medical Center

VA HSR&D Center of Innovation (152)

2002 Holcombe Boulevard

Houston, TX, 77030

United States

Phone: 1 713 794 8601

Fax:1 713 748 7359

Email: hardeeps [at] bcm.edu

ABSTRACT

Background: Despite visits to multiple physicians, many patients remain undiagnosed. A new online program, CrowdMed, aims to leverage the “wisdom of the crowd” by giving patients an opportunity to submit their cases and interact with case solvers to obtain diagnostic possibilities.

Objective: To describe CrowdMed and provide an independent assessment of its impact.

Methods: Patients submit their cases online to CrowdMed and case solvers sign up to help diagnose patients. Case solvers attempt to solve patients’ diagnostic dilemmas and often have an interactive online discussion with patients, including an exchange of additional diagnostic details. At the end, patients receive detailed reports containing diagnostic suggestions to discuss with their physicians and fill out surveys about their outcomes. We independently analyzed data collected from cases between May 2013 and April 2015 to determine patient and case solver characteristics and case outcomes.

Results: During the study period, 397 cases were completed. These patients previously visited a median of 5 physicians, incurred a median of US $10,000 in medical expenses, spent a median of 50 hours researching their illnesses online, and had symptoms for a median of 2.6 years. During this period, 357 active case solvers participated, of which 37.9% (132/348) were male and 58.3% (208/357) worked or studied in the medical industry. About half (50.9%, 202/397) of patients were likely to recommend CrowdMed to a friend, 59.6% (233/391) reported that the process gave insights that led them closer to the correct diagnoses, 57% (52/92) reported estimated decreases in medical expenses, and 38% (29/77) reported estimated improvement in school or work productivity.

Conclusions: Some patients with undiagnosed illnesses reported receiving helpful guidance from crowdsourcing their diagnoses during their difficult diagnostic journeys. However, further development and use of crowdsourcing methods to facilitate diagnosis requires long-term evaluation as well as validation to account for patients’ ultimate correct diagnoses.

J Med Internet Res 2016;18(1):e12

doi:10.2196/jmir.4887

KEYWORDS

Posted in Events, Fifth Avenue Concierge Medicine, Health, keto, News | Tagged , |

Risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy

The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: A systematic review and meta-analysis

 

 

http://onlinelibrary.wiley.com/doi/10.1111/bcp.12849/abstract

  1. Anick Bérard1,2,*,
  2. Noha Iessa1,2,
  3. Sonia Chaabane1,2,
  4. Flory T. Muanda1,2,
  5. Takoua Boukhris1,2 and
  6. Jin-Ping Zhao1,2

DOI: 10.1111/bcp.12849

Article has an altmetric score of 190

Additional Information(Show All)

Author InformationPublication History

  1. This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/bcp.12849.

SEARCH

Keywords:

  • Paroxetine;
  • pregnancy;
  • major malformations;
  • cardiac malformations;
  • meta-analysis

Aims

The aim of this study was to perform an up-to-date meta-analysis on the risk of cardiac malformations associated with gestational exposure to paroxetine, taking into account indication, study design, and reference category.

Method

A systematic review of studies published between 1966 and November 2015 was conducted using EMBASE and MEDLINE. Studies reporting major malformations with first trimester exposure to paroxetine were included. Potentially relevant articles were assessed and relevant data extracted to calculate risk estimates. Outcomes included any major malformations, and major cardiac malformations. Pooled odds ratios and 95% confidence intervals were calculated using random-effects models.

Results

Twenty-three studies were included. Compared to non-exposure to paroxetine, first trimester use of paroxetine was associated with an increased risk of any major congenital malformations combined (pooled OR 1.23, 95% CI 1.10, 1.38; n=15 studies); major cardiac malformations (pooled OR 1.28, 95% CI 1.11, 1.47; n=18 studies), specifically bulbus cordis anomalies and anomalies of cardiac septal closure (pooled OR 1.42, 95% CI 1.07, 1.89; n=8 studies), atrial septal defects (pooled OR 2.38, 95% CI 1.14, 4.97; n=4 studies), and right ventricular outflow track defect (pooled OR 2.29, 95% CI 1.06, 4.93; n=4 studies). Although the estimates varied depending on the comparator group, study design and malformation detection period, a trend towards increased risk was observed.

Conclusions

Paroxetine use during the first trimester of pregnancy is associated with an increased risk of any major congenital malformations and cardiac malformations. The increase in risk is not dependent on the study method or population.

Posted in Aging, China, dietary, epigenetics, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged , , |

Stress resilience and subsequent risk of type 2 diabetes in 1.5 million young men

 

 

http://link.springer.com/article/10.1007/s00125-015-3846-7

  • Casey Crump 
  • , Jan Sundquist
  • , Marilyn A. Winkleby
  • , Kristina Sundquist

$39.95 / €34.95 / £29.95 *

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Aims/hypothesis

Psychosocial stress in adulthood is associated with a higher risk of type 2 diabetes, possibly mediated by behavioural and physiological factors. However, it is unknown whether low stress resilience earlier in life is related to subsequent development of type 2 diabetes. We examined whether low stress resilience in late adolescence is associated with an increased risk of type 2 diabetes in adulthood.

Methods

We conducted a national cohort study of all 1,534,425 military conscripts in Sweden during 1969–1997 (97–98% of all 18-year-old men nationwide each year) without prior diagnosis of diabetes, who underwent standardised psychological assessment for stress resilience (on a scale of 1–9) and were followed up for type 2 diabetes identified from outpatient and inpatient diagnoses during 1987–2012 (maximum attained age 62 years).

Results

There were 34,008 men diagnosed with type 2 diabetes in 39.4 million person-years of follow-up. Low stress resilience was associated with an increased risk of developing type 2 diabetes after adjusting for BMI, family history of diabetes, and individual and neighbourhood socioeconomic factors (HR for lowest vs highest quintile: 1.51; 95% CI 1.46, 1.57; p < 0.0001), including a strong linear trend across the full range of stress resilience (p trend < 0.0001). This association did not vary by BMI level, family history of diabetes or socioeconomic factors.

Conclusions/interpretation

These findings suggest that low stress resilience may play an important long-term role in aetiological pathways for type 2 diabetes. Further elucidation of the underlying causal factors may help inform more effective preventive interventions across the lifespan.

Keywords

Psychological resilience Psychological stress Type 2 diabetes mellitus

Posted in Aging, dietary, epigenetics, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged , , , , , , , , |

Cognitive effects of intentional weight loss in elderly obese individuals with mild cognitive impairment

 

 

http://press.endocrine.org/doi/abs/10.1210/jc.2015-2315

Cognitive effects of intentional weight loss in elderly obese individuals with mild cognitive impairment

Address all correspondence and requests for reprints to: Dr.Nidia Celeste Horie Ph.D. nidiachorie@yahoo.com.br

Faculdade de Medicina da Universidade de São Paulo – Endocrinology R Dr Ené as de Carvalho Aguiar, 155 8andar, Endocrinologia Sao Paulo SP BRAZIL 05403–000 55–011–99640 6475

.

Received: May 17, 2015
Accepted: December 11, 2015
First Published Online: December 29, 2015

Abstract

Context:

Obesity in midlife is a risk factor for dementia, but it is unknown if caloric restriction-induced weight loss could prevent cognitive decline and therefore dementia in elderly patients with cognitive impairment.

Objective:

To evaluate the cognitive effect of intentional weight loss in obese elderly patients with mild cognitive impairment (MCI), considering the influence of age, apolipoprotein E genotype (APOE), physical activity, biochemical markers and diet.

Design:

Single-center, prospective controlled trial.

Setting:

Academic medical center

Participants:

Eighty obese patients with MCI, aged 60 or older (68.1±4.9 years, body mass index (BMI) 35.5±4.4kg/m2, 83.7% women, 26.3% APOE4 carriers).

Intervention:

Random allocation to conventional medical care alone (n=40) or together with nutritional counselling (n=40) in group meetings aiming to promote weight loss through caloric restriction for 12 months.

Outcome:

Measurements: Clinical data, body composition, neuropsychological tests (main outcome), serum biomarkers, APOE genotype, physical performance, dietary recalls.

Results:

Seventy-five patients completed the follow-up. BMI, on average, decreased 1.7 ±1.8kg/m2 (p=0.021), and most of the cognitive tests improved, without difference between the groups. In analysis with linear generalized models, the BMI decrease was associated with improvements in verbal memory, verbal fluency, executive function and global cognition, after adjustment for education, gender, physical activity and baseline tests: this association was strongest in younger seniors (for memory and fluency) and in APOE4 carriers (for executive function). Changes in HOMA-IR, C-reactive protein, leptin and intake of energy, carbohydrates and fats were associated with improvement in cognitive tests.

Conclusions:

Intentional weight loss through diet was associated with cognitive improvement in patients with MCI.

Affiliations
  • 1Obesity and Metabolic Syndrome Group- Sao Paulo University, School of Medicine;
  • 2Psychology Division- Hospital das Clínicas, Sao Paulo University;
  • 3Institute of Psychiatry – Sao Paulo University, School of Medicine;
  • 4Nutrition Division- Clinical Hospital – Sao Paulo University, School of Medicine;
  • 5Discipline of Geriatrics – Sao Paulo University, School of Medicine;
  • 6Division of Clinical Immunology and Allergy- Sao Paulo University, School of Medicine

– See more at: http://press.endocrine.org/doi/abs/10.1210/jc.2015-2315#sthash.JzKKeyZO.dpuf

Posted in Aging, dietary, epigenetics, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged |